Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -26.29% is 47% above its 5-year average of -49.44%, around the middle of its 5-year range (-78.81%–68.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 37.69% above its 12-month average of -42.19%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -26.29%.
RETURN ON INVESTED CAPITAL (ROIC)
-26.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-53.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-49.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-69.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+37.69%
CURRENT VS 3Y AVG
+50.48%
CURRENT VS 5Y AVG
+46.82%
CURRENT VS 10Y AVG
+62.04%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+21.53%
vs the sector median at left
Ovid Therapeutics Inc.
Market Cap
$445.14M
Return on Invested Capital (ROIC)
-26.29%
TTM Avg
-42.19%
3Y Avg
-53.09%
5Y Avg
-49.44%
Market Cap
$446.12M
Return on Invested Capital (ROIC)
-18.95%
TTM Avg
-22.72%
3Y Avg
-28.68%
5Y Avg
-26.80%
Market Cap
$449.00M
Return on Invested Capital (ROIC)
-100.87%
TTM Avg
-63.16%
3Y Avg
-52.79%
5Y Avg
-48.48%
Market Cap
$440.34M
Return on Invested Capital (ROIC)
-2.86%
TTM Avg
-34.72%
3Y Avg
-61.44%
5Y Avg
-57.77%
Market Cap
$437.94M
Return on Invested Capital (ROIC)
-40.25%
TTM Avg
-30.86%
3Y Avg
-64.07%
5Y Avg
-59.14%
Market Cap
$435.06M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
Market Cap
$431.16M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$462.12M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$468.47M
Return on Invested Capital (ROIC)
-29.50%
TTM Avg
-37.63%
3Y Avg
-38.70%
5Y Avg
-37.47%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | $445.14M | -26.29% | -42.19% | -53.09% | -49.44% |
| NeuroPace, Inc. (NPCE)vs › | $446.12M | -18.95% | -22.72% | -28.68% | -26.80% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $449.00M | -100.87% | -63.16% | -52.79% | -48.48% |
| Assembly Biosciences, Inc. (ASMB)vs › | $440.34M | -2.86% | -34.72% | -61.44% | -57.77% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $437.94M | -40.25% | -30.86% | -64.07% | -59.14% |
| Editas Medicine, Inc. (EDIT)vs › | $435.06M | -48.61% | -80.33% | -62.04% | -50.84% |
| NeoGenomics, Inc. (NEO)vs › | $431.16M | -5.29% | -5.58% | -6.88% | -5.95% |
| NRC Health (NRC)vs › | $462.12M | 8.75% | 20.32% | 26.86% | 29.17% |
| Sight Sciences, Inc. (SGHT)vs › | $468.47M | -29.50% | -37.63% | -38.70% | -37.47% |
| Senseonics Holdings, Inc. (SENS)vs › | $420.85M | -71.22% | -79.15% | -65.81% | -107.73% |
ROIC
-26.3%
ROE
-16.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -26.29% |
| 2026-03-31 | -22.59% |
| 2025-12-31 | -29.75% |
| 2025-09-30 | -71.63% |
| 2025-06-30 | -60.68% |
| 2025-03-31 | -78.81% |
| 2024-12-31 | -75.79% |
| 2024-09-30 | -76.19% |
| 2024-06-30 | -64.74% |
| 2024-03-31 | -50.37% |
| 2023-12-31 | -44.72% |
| 2023-09-30 | -45.77% |
| 2023-06-30 | -42.86% |
| 2023-03-31 | -39.41% |
| 2022-12-31 | -37.46% |
| 2022-09-30 | -44.05% |
| 2022-06-30 | -40.81% |
| 2022-03-31 | -37.94% |
| 2021-12-31 | 68.36% |
| 2021-09-30 | 64.61% |
| 2021-06-30 | 59.15% |
| 2021-03-31 | 51.97% |
| 2020-12-31 | -151.18% |
| 2020-09-30 | -104.71% |
| 2020-06-30 | -251.78% |
| 2020-03-31 | -130.77% |
| 2019-12-31 | -87.34% |
| 2019-09-30 | -188.77% |
| 2019-06-30 | -117.37% |
| 2019-03-31 | -91.42% |
| 2018-12-31 | -136.41% |
| 2018-09-30 | -101.79% |
| 2018-06-30 | -77.06% |
| 2018-03-31 | -61.28% |
| 2017-12-31 | -77.91% |
| 2017-09-30 | -66.21% |
| 2017-06-30 | -57.41% |
| 2017-03-31 | -125.39% |
| 2016-12-31 | -45.71% |
| 2016-09-30 | -32.78% |
